SAN DIEGO, May 1, 2012 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced that a paper reporting on a multi-site refractive surgery center study designed to determine if pre-operative tear osmolarity levels relate to visual acuity outcomes following LASIK surgery will be presented at the Association for Research in Vision and Ophthalmology ("ARVO") Annual Meeting in Fort Lauderdale, Florida.
